This link is also supported by studies showing that Reelin levels are reduced in patients with schizophrenia and bipolar disorder (Fatemi et al., 2000; Torrey et al., 2005; Ruzicka et al., 2007), and can be altered by psychotropic medication (Fatemi et al., 2009). Here, RELN is linked to schizophrenia.